Our findings also cemented this paradoxical activation by ERK5i and we found treatment with XMD8-92 was not able to effectively reduce tumor metastasis but ERK5 knockdown itself proved to be an efficient strategy to mitigate OSCC metastasis. The gene discussed is MAPK7; the disease is neoplasm.